एपीए उद्धरण

Shitara, K., Van Cutsem, E., Bang, Y., Fuchs, C., Wyrwicz, L., Lee, K., . . . Tabernero, J. (2020). Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial. JAMA Oncol.

शिकागो स्टाइल उद्धरण

Shitara, Kohei, et al. "Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy Vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial." JAMA Oncol 2020.

एमएलए उद्धरण

Shitara, Kohei, et al. "Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy Vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial." JAMA Oncol 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.